Adamax
Experimental Peptide
Adamax is a vendor-associated name for a modified Semax-like research peptide. Its exact sequence, purity standard, route behavior, and human evidence are not established in indexed literature. It must not inherit Semax dosing or pharmacology.
Pharmacokinetic model
A route-level PK model for adamax is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Experimental Peptide
- Suggested cadence
- once daily
Research behind this entry
-
The efficacy of Semax in the treatment of patients at different stages of ischemic stroke
This clinical study administered Semax during stroke rehabilitation and reported BDNF and functional outcomes. It is included only as indirect parent-analogue context: Semax is not Adamax and the study supplies no…
1 published study referenced in the app, each with a plain-language summary.